Skip to main content
Year archive

RemeGen Co., Ltd. — 2026 filings

All 31 regulatory filings released by RemeGen Co., Ltd. (9995) in 2026, sourced directly from the official regulator.

31 Filings
2026 Period
2026 filings (31)
Filing Released Lang
荣昌生物制药（烟台）股份有限公司关于参加“对话成长”2025年度暨2026年一季度集体业绩说明会的公告
Regulatory Filings
2026-05-06 Chinese
DATE OF BOARD MEETING
Report Publication Announcement
2026-04-16 English
VOLUNTARY ANNOUNCEMENT - Receipt of US$650 Million Upfront Payment from AbbVie under the Exclusive License Agreement for RC148
Regulatory Filings
2026-04-15 English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
Regulatory Filings
2026-04-14 English
VOLUNTARY ANNOUNCEMENT - Approval of the New Drug Application for Disitamab Vedotin for the Indication of HER2-Expressing Urothelial Carcinoma
Regulatory Filings
2026-04-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
Regulatory Filings
2026-04-09 English
Voluntary Announcement - NMPA APPROVES THE CLINICAL TRIAL OF BISPECIFIC ANTIBODY-DRUG CONJUGATE (BISPECIFIC ADC) RC288 FOR INJECTION
Regulatory Filings
2026-04-01 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2026-03-29 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2026-03-29 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2026-03-29 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2026-03-29 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2026-03-29 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2026-03-29 English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2025
Regulatory Filings
2026-03-27 English
VOLUNTARY ANNOUNCEMENT - Approval of the New Drug Application for Disitamab Vedotin for the Indication of HER2-Low Breast Cancer with Liver Metastases
Regulatory Filings
2026-03-23 English
DATE OF BOARD MEETING
Report Publication Announcement
2026-03-17 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026
Regulatory Filings
2026-03-04 English
INSIDE INFORMATION - 2025 ANNUAL RESULTS UPDATE ANNOUNCEMENT
Earnings Release FY 2025
2026-02-27 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2026-02-27 English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026
Share Issue/Capital Change
2026-02-25 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026
Share Issue/Capital Change
2026-02-05 English
Monthly Return of Equity Issuer on Movement in Securities for the month ended 31 January 2026
Share Issue/Capital Change
2026-02-02 English
INSIDE INFORMATION - ESTIMATED 2025 ANNUAL RESULTS
Earnings Release FY 2025
2026-01-30 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2026-01-21 English
Next Day Disclosure Return
Transaction in Own Shares
2026-01-21 English
ANNOUNCEMENT ON THE FIRST SHARE REPURCHASE AND THE COMPLETION OF THE SHARE REPURCHASE PLAN
Transaction in Own Shares
2026-01-21 English
ANNOUNCEMENT ON THE ADJUSTMENT TO THE UPPER LIMIT OF THE PRICE OF A SHARE REPURCHASE
Transaction in Own Shares
2026-01-15 English
INSIDE INFORMATION - Announcement on Signing a License Agreement with AbbVie
Capital/Financing Update
2026-01-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025
Regulatory Filings
2026-01-07 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2026-01-05 English
Monthly Return of Equity Issuer on Movement in Securities for the month ended 31 December 2025
Share Issue/Capital Change
2026-01-05 English